These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 1942938

  • 1. [Increased expression of the MYCN oncogene in human neuroblastoma cells and possible, new therapeutic approaches].
    Schweigerer L, Fotsis T.
    Klin Padiatr; 1991; 203(4):319-22. PubMed ID: 1942938
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S.
    Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
    Tanaka N, Fukuzawa M.
    Int J Oncol; 2008 Oct 15; 33(4):815-21. PubMed ID: 18813796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
    Gross N, Balmas Bourloud K, Brognara CB.
    Exp Cell Res; 2000 Nov 01; 260(2):396-403. PubMed ID: 11035936
    [Abstract] [Full Text] [Related]

  • 9. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D.
    Cancer Res; 1994 Aug 01; 54(15):4238-42. PubMed ID: 7518353
    [Abstract] [Full Text] [Related]

  • 10. Localization of regulatory elements controlling human MYCN expression.
    Hiller S, Breit S, Wang ZQ, Wagner EF, Schwab M.
    Oncogene; 1991 Jun 01; 6(6):969-77. PubMed ID: 2067849
    [Abstract] [Full Text] [Related]

  • 11. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E, Da Silva J, Riou G, Bénard I.
    Cancer Res; 1994 Apr 15; 54(8):2256-61. PubMed ID: 8174136
    [Abstract] [Full Text] [Related]

  • 12. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.
    Lutz W, Fulda S, Jeremias I, Debatin KM, Schwab M.
    Oncogene; 1998 Jul 23; 17(3):339-46. PubMed ID: 9690515
    [Abstract] [Full Text] [Related]

  • 13. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
    Kavallaris M, Gardaneh M, Cheung B, Camacho ML, Hocker JE, Norris MD, Haber M, Marshall GM.
    Anticancer Res; 1998 Jul 23; 18(3A):1793-7. PubMed ID: 9673406
    [Abstract] [Full Text] [Related]

  • 14. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G, Cesi V, Amendola R, Negroni A, Tanno B, Altavista P, Tonini GP, De Bernardi B, Calabretta B.
    Cancer Res; 1999 Jul 15; 59(14):3365-8. PubMed ID: 10416595
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 15; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 17. High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome.
    Schramm A, von Schuetz V, Christiansen H, Havers W, Papoutsi M, Wilting J, Schweigerer L.
    Oncogene; 2005 Jan 20; 24(4):680-7. PubMed ID: 15580313
    [Abstract] [Full Text] [Related]

  • 18. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT.
    J Clin Oncol; 2005 Sep 20; 23(27):6466-73. PubMed ID: 16116152
    [Abstract] [Full Text] [Related]

  • 19. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors.
    Wittrock J, Schweizer P, Girgert R.
    Anticancer Res; 2002 Sep 20; 22(6C):4205-9. PubMed ID: 12553057
    [Abstract] [Full Text] [Related]

  • 20. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
    Chen J, Liu T, Zhe X, Jiang J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun 20; 21(3):197-202. PubMed ID: 12569653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.